Physician profile
Peter L Stone
NPI 1518071729
$2,947.71
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,507 · 2020: $417 · 2023: $23.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $454.56 | 2019-2020 | |
| Astellas Pharma US INC | $311.52 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $279.80 | 2019-2020 | |
| Pfizer INC. | $237.21 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $198.90 | 2019-2020 | |
| Tolmar Pharmaceuticals, INC. | $187.96 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $166.09 | 2019-2020 | |
| Allergan, INC. | $156.74 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $153.45 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.05 | 2019-2020 | |
| Blue Earth Diagnostics | $101.34 | 2019 | |
| Aytu Biopharma, INC. | $97.36 | 2019-2020 | |
| Abbvie INC. | $92.32 | 2019-2023 | Botox |
| Amgen INC. | $81.43 | 2019-2020 | |
| Neotract INC. | $79.26 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih INC. | $61.74 | 2019 | |
| Photocure INC | $47.09 | 2019 | |
| Boston Scientific Corporation | $34.60 | 2020 | |
| Coloplast Corp | $30.84 | 2019 | |
| Merck Sharp & Dohme LLC | $15.95 | 2020 | |
| Rochester Medical Corporation | $12.28 | 2019 | |
| Metuchen Pharmaceuticals | $11.62 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Stone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.